Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Vaxart touts head-to-head data for oral flu vaccine versus Sanofi's Fluzone

fiercepharmaNovember 09, 2018

Tag: Influenza , Vaccine development , Vaxart

PharmaSources Customer Service